+ Home
+ Contact
News
Press Releases
November 14, 2011
Lentigen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer [pdf]
November 3, 2010
LENTIGEN AWARDED $1.2 MILLION By U.S. Government Under the Qualifying Therapeutic Discovery Project [pdf]
August 9, 2010
Lentigen Awarded Phase II SBIR Grant for Clinical Development of TCR Immunotherapy Targeted to Melanoma [pdf]
May 18, 2010
Lentigen Awarded Phase I STTR Grant For Hunter Syndrome [pdf]
April 22, 2010
IAVI and Lentigen to Collaborate on Design of Novel AIDS Vaccine Candidate [pdf]
December 9, 2009
Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine [pdf]
February 4, 2009
Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement [pdf]
December 4, 2008
Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza [pdf]
October 1, 2008
Lentigen Corporation and The United States Army Agree to Contract [pdf]
September 8, 2008
Lentigen Corporation Announces Relocation to New Facility [pdf]
August 4, 2008
Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression [pdf]
June 16, 2008
Lentigen Appoints Jim Meade as Vice President of Corporate Development [pdf]
May 15, 2008
Lentigen Corporation Receives Four Research Grants From The National Institutes of Health [pdf]
April 3, 2008
Lentigen Licenses Fundamental Lentiviral Vector Technology Patent from the University of Cambridge [pdf]
March 20, 2008
Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer [pdf]
February 13,2008
Lentigen to Move Headquarters and Manufacturing to Gaithersburg [pdf]
January 28, 2008
Lentigen Appoints Tim Ravenscroft as Chief Executive Officer [pdf]
December 20, 2007
Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million [pdf]
September 17, 2007
Lentigen Corporation Partners with Thermo Fisher Scientific [pdf]
June 20, 2007
Lentigen Corporation Named Best Life Science Company in 7th Annual Maryland Incubator Company of the Year Awards [pdf]
January 25, 2007
Lentigen Corporation and Wave Biotech, LLC Announce Formation of Collaboration [pdf]
December 4, 2006
World Economic Forum Announces Technology Pioneers 2007: Lentigen Selected [pdf]
November 30, 2006
Lentigen Receives Grant from NIH to Develop Potential New Therapy for Treatment of Chronic Lymphocytic Leukemia [pdf]
November 20, 2006
Lentigen Appoints Adam L. Sachs to President, Commercial Operations [pdf]
October 17, 2006
Lentigen Receives Grant from NIH to Evaluate Use of Lentiviral-Engineered T-Cells for Cancer Immunotherapy
September 26, 2006
Mid-Atlantic Life Sciences Companies Chosen to Present at 2006 Mid-Atlantic Bio
September 7, 2006
Lentigen Announces Second Collaborative Research Agreement with the University of Pennsylvania [pdf]
August 30, 2006
Lentigen And Dharmacon Collaborate To Develop Custom Lentiviral Reagents For RNAi Research [pdf]
July 27, 2006
Lentigen Corporation and The University Of Pennsylvania Announce Collaborative Research Agreement [pdf]
May 30, 2006
Lentigen Corporation and United States Army Enter into a Cooperative Research and Development Agreement [pdf]
May 22, 2006
Lentigen Corporation Recognized as Leading Innovator by Red Herring Magazine [pdf]
May 19, 2006
Lentigen Corporation and the University of Pennsylvania Enter Intellectual Property License Agreement [pdf]
February 2, 2006
Lentigen Corporation is Recipient of First Maryland Technology Champions Awards [pdf]
January 30, 2006
Lentigen Corporation and Evrogen JSC Enter License Agreement for Novel Fluorescent Protein Technology [pdf]
January 9, 2006
Lentigen Corporation and ZGene A/S Enter License Agreement for Selected ZGene Intellectual Property [pdf]
December 13, 2005
Lentigen Corporation Receives Funding from the State of Maryland [pdf]
December 6, 2005
Lentigen Corporation and Omnia Biologics Announce Strategic Alliance Related to Lentiviral Vector Manufacturing [pdf]
December 2, 2005
Lentigen Corporation Strengthens Management Team [pdf]
November 30, 2005
Lentigen Corporation Secures Financing from Greenwich Biotech Ventures [pdf]
November 14, 2005
Lentigen Corporation Launches First Website Allowing On-line Custom Lentiviral Vector Design [pdf]
August 15, 2005
Omnia Biologics And Lentigen Sign Manufacturing Agreement [pdf]
July 22, 2005
UMBC Welcomes Another Biotechnology Company [pdf]
 
Media Coverage
November 26, 2008
Scientific American |
"Scientific American's Steve Mirsky talks to Boro Dropulic about converting viruses into disease fighters."
June 15, 2008
Genetic Engineering & Biotechnology News |
"TechUpdate: Are Lentiviral Vectors on Cusp of Breakout?"
September 25, 2006
Baltimore Business Journal |
"Lentigen to Present at the Mid-Atlantic Bio Conference"
July 12, 2006
Drug Discovery News |
"Lentigen's R&D Deal with U.S. Army Promotes Lentiviral Vectors"
May 30, 2006
Baltimore Business Journal |
"Lentigen, Army Team on Biodefense Research"
March 31, 2006
The Scientist |
"Flu Vaccines: Looking Beyond Eggs"
January 24, 2006
Drug Discovery News |
"Gene Therapy and Beyond: Leveraging Lentiviruses"
November 15, 2005
Genetic Engineering News |
"Applications Go Beyond Vaccines and Gene Therapy to include Drug Discovery Research"
 
 
Background_waves
Background_footer
© Copyright 2008 Lentigen Corp. All Rights Reserved.    + Privacy Policy    + Terms of Use